Page last updated: 2024-10-25

cystamine and Acquired Immunodeficiency Syndrome

cystamine has been researched along with Acquired Immunodeficiency Syndrome in 2 studies

Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDonnell, NB1
De Guzman, RN1
Rice, WG1
Turpin, JA1
Summers, MF1
JELLUM, E1

Other Studies

2 other studies available for cystamine and Acquired Immunodeficiency Syndrome

ArticleYear
Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS.
    Journal of medicinal chemistry, 1997, Jun-20, Volume: 40, Issue:13

    Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Anti-HIV Agents; Capsid; Capsid Proteins; C

1997
INTERACTION OF CYSTAMINE AND CYSTAMINE DERIVATIVES WITH NUCLEIC AIDS AND NUCLEOPROTEINS.
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1965, Volume: 9

    Topics: Acquired Immunodeficiency Syndrome; Animals; Biochemical Phenomena; Biochemistry; Cattle; Cell Nucle

1965